3^rd International Conference on Applied Microbiology and Infectious Diseases August 30-31, 2022 Vancouver, Canada

Our Conference will provide a perfect platform addressing:

•          Laudable talks by the top-notch of the global scientific community

•          Sterling workshop sessions

•          Remarkable Awards and Global Recognition to meritorious Researchers

•          Global Networking with 50+ Countries

•          Novel Techniques to Benefit Your Research

Track 1: Microorganisms in Pharmaceutical Industry

The most critical commitment of microbiology to the pharmaceutical business is the improvement of anti-infection agents. All anti-infection agents were initially the results of microbial digestion; however the recent research has enabled the production of more improved medications. Vaccines are likewise an important contribution of microbiology towards the drug development. Vaccine production usually requires culturing of huge amounts of bacteria. Steroids are also produced from microorganisms. Microbiology also contributes towards quality control of a pharmaceutical 

Track 2: Probiotics & Prebiotics

Probiotics are contained with a range of food and nutrition products such as dietary supplements, medicinal foods, biopharmaceuticals and medical devices delivering probiotics. Prebiotics foods are taken as dietary ingredients to maintain the Biological Symbiosis with the microbial flora. Dietary supplements created through the synergism of Pro and Pre-biotic are the Synbiotics. The nutrition supplemented with the beneficial microbial flora and the associated microbiome in human gut, restoring the human digestive system as a whole is said to be the “Probiotics”.

Track 3: Applied microbiology

Applied microbiology is a scientific discipline that deals with the application of microorganisms and the cognizance about them. Applications include biotechnology, agriculture, medicine, aliment microbiology and bio remediation. Systematic and Applied Microbiology deals with sundry aspects of microbial diversity and systematics of prokaryotes.

Track 4: Environmental biology

Environmental biology is that the study of the composition and physiology of microbic communities within the atmosphere. The atmosphere during this case means that the soil, water, air and sediments covering the earth and may additionally embrace the animals and plants that inhabit these areas. Environmental biology additionally includes the study of microorganisms that exist in artificial environments like bioreactors. Molecular biology has revolutionized the study of microorganisms within the atmosphere and improved our understanding of the composition, phylogeny, and physiology of microbic communities. This molecular tool case encompasses a spread of DNA-based technologies and new strategies for the study of polymer and proteins extracted from environmental samples. Presently there's a serious stress on the applying  approaches to see the identities and functions of microbes inhabiting totally different atmosphere.

Track 5: Bacteriology

The science and study of bacterium and their regard to medication and to alternative areas like agriculture (e.g., farm animals) and business. Bacteriology may be a part of biological science that encompasses the study of bacterium, viruses, and every one alternative type of microorganisms.

Track 6: Microbiology & Microbes World

Pure Microbiology which provides a major platform of a large plethora of research and plenty of new insights into different areas of Microbiology.  There are different branches of Microbiology such as, mycology, Virology, Immunology, infectious diseases, bacteriology, nematology, parasitology, etc. In against of pathogenic bacteria which can we used that is antibiotics either orally or paternally. The USA has about $66.28 billion worth of antibiotics that are manufactured annually, is expected to attain $75 billion by the end of 2018.

Track 7: Applied Microbiology In Animals

Novel aspects of applied microbiology in relation to animal health, it is intended to describe and enhance understanding of the role of microorganisms in animal health and disease, and provides an excellent grounding in microbiology molecular biology, immunology and epidemiology.This grounding leads into the study of the complex mechanisms of host/microbe interactions that are involved in the pathogenesis of specific animal diseases, and provides insights into diagnosis and interventions, such as vaccines, essential for disease control. This is concerned with microbial (bacterial, fungal, viral) diseases of domesticated vertebrate animals (livestock, companion animals, fur-bearing animals, poultry, but excluding fish) that supply food, other useful products or companionship. In addition, Microbial diseases of wild animals living in captivity, or as members of the feral fauna will also be considered if the infections are of interest because of their interrelation with humans and/or domestic animals.

Track 8: Human Micro biota

The collection of microbes living in and on our body - have a significant impact on human health and well-being. They have been associated with numerous diseases, yet we have barely understood their role in the context of life-style and genetics. Various initiatives are underway around the world to survey the human micro biota at several body sites, characterise them, understand their interactions with the human hosts, elucidate their role in diseases, and design possible therapeutic or dietary interventions.

Track 9: Public health & Epidemiology

Public health is "the science and art of preventing disease, prolonging life and promoting human health through organized efforts and informed choices of society, organizations, public and private, communities and individuals". Public health aims to improve the quality of life through prevention and treatment of disease, including mental health. This is done through the surveillance of cases and health indicators, and through the promotion of healthy behaviours. Public health refers to all organized measures to prevent disease, promote health, and prolong life among the population. Its activities aim to provide conditions in which people can be healthy and focus on entire populations, not on individual patients or diseases. Modern public health practice requires multidisciplinary teams of public health workers and professionals. Teams might include epidemiologists, biostatisticians, medical assistants, public health nurses, midwives or medical microbiologists. Depending on the need environmental health officers or public health inspectors, bioethicists, and even veterinarians, Gender experts, Sexual and reproductive health specialists.

Track 10: Oral Microbiology

The study of the microorganisms of the oral cavity and their interactions between oral microorganisms or with the host is generally known as Oral Microbiology. The growth of characteristics microorganisms depends on the environment present in the human mouth found there. Oral bacteria have evolved mechanisms to sense their environment and modify the host.  Water, nutrients as well as a moderate temperature are some of the common source provided for the survival of these microbes. The resident microbes present in the mouth adhere to the teeth and gums to resist the mechanical flushing from the mouth to stomach. After reaching to stomach the acid-sensitive microbes are destroyed by hydrochloric acid.

Track 11: Infectious diseases

Infectious diseases are caused by pathogenic microbes which spread either directly or indirectly from one person to another. These can be classified as either bacterial, viral, zoonotic, parasitic or fungal depending on causative agents. Most of infections are not lethal and organism is annihilated after the symptoms wane. The process requires immune mechanisms to kill the source of the pathogen. Specific acquired immunity antagonistic to the infectious diseases are mediated by either antibodies or by T lymphocytes. The immune response causes high fever, inflammation, and also has the probability to be devastating to a microbe. Phylodynamic models help in locating the epidemic and pandemic origins. The agile rate of evolution and growth in viruses allows molecular clocks to envisage the genetic sequences, thereby providing the precise rate of evolution of the virus.

Track 12: Bacterial diseases

Bacterial disease, any of a variety of illnesses caused by bacteria. Until the mid-20th century, bacterial pneumonia was probably the leading cause of death among the elderly. Improved sanitation, vaccines, and antibiotics have all decreased the mortality rates from bacterial infections, though antibiotic-resistant strains have caused resurgence in some illnesses. In the early 21st century, tuberculosis, which is caused by Mycobacterium tuberculosis—several strains of which had developed resistance to one or more drugs widely used to treat the infection—was among the deadliest infectious diseases worldwide.

Applied Microbiology 2022 brings you an immense opportunity to be a part of scientific acceleration to world class personalities, young scholars, scientific delegates and young scientists to join in this Conference to utilize the expertise and novelties that brings a new era for innovations in the field of Microbiology, Immunology, and Pathology which brings well versed scrutinizers at one place. It provides a platform to have open discussions, knowledge sharing and interactive sessions with field experts at Applied Microbiology 2020. We request you to submit a brief idea or abstract of your talk/presentation/symposium/workshop according to your session interest. Please follow the format of our Sample Template.

Abstract Submission Deadline: August 30-31, 2022

For abstract submission visit: https://appliedmicrobiology.annualcongress.com/abstract-submission.php

Applied Microbiology, the study of microbes, is an unparalleled branch of life sciences. With immensely high prevalence of diseases such as flu, hepatitis, AIDS, and STDs, the importance of Microbiology is repeatedly highlighted. The global Microbiology market is expected to grow over 2014-2025.

Global Applied Microbiology

The global virology market is estimated at $1693 million in 2017 and is estimated to grow at a CAGR of 5.4% during the forecast period 2018-2023. North America is the largest virology market led by the U.S., owing to technological advancements such as rapid, portable diagnostics. N. America is expected to retain the top market position over the forecast period as well.

Europe is projected to maintain the position as the second largest market globally. During the forecast period, Europe is anticipated to record the highest CAGR, attributed by enhanced healthcare infrastructure, facilitated access to diagnostics, and growing affordability of diagnostic tests for viral diseases.

Vancouver is currently a growing microbiology market, which is estimated to grow at a remarkable CAGR through to 2025. However, APEJ and Africa are expected to witness the most promising growth opportunities during the forecast period. While China will be a leading APEJ market, India will contribute a considerable revenue share to the APEJ virology market.

Key Players in the Global Microbilogy Market

The notable players identified in the global virology market include GlaxoSmithKline plc, Abbott Laboratories, Boehringer  Ingelheim Corporation, Merck and Co. Inc., Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche.

Merck and Co. Inc. has several drug candidates in phase 2, including cancer, diabetes, cardiac arrest, and hepatitis C, and some candidates in phase 3, including breast cancer, atherosclerosis, Alzheimer's, Ebola, and HIV. The company also has many other candidates, which are currently under review.

Abivax, a high-profile biotech company in Paris, France, has already successfully produced candidates against dengue and chikungunya viruses. The company has a few more candidates against HIV and Ebola, currently under development.

On the basis of diagnosis tests, hepatitis B, Hepatitis C, HIV, Human papillomavirus (HPV), and other tests (like influenza, Ebola, and dengue) are estimated to hold the largest market share globally during the forecast period. Viral Infection controlling Methods include Immunoprophylaxis, Active Prophylaxis (Vaccines), Passive Prophylaxis, Antiviral Chemotherapy (Veridical Agents, Antiviral Agents, Immunomodulators), Interferon’s (Cytokines). Immunoprophylaxis therapy and antiviral drugs are the fastest growing market segments in the estimated forecast period.

Virology Market is segmented By Applications into Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract infection, Eye Infections, Sexually Transmitted Diseases, Perinatal Infections. STDs, Urinary tract infections, and respiratory tract infections are currently dominating as compared to the other application types in the global virology market. Virology Market is segmented By End Users into Hospitals, Clinics, Laboratories, Diagnostic Centres, Blood Banks, and Pharmacies.

Global Vaccines Market:

The global vaccine market is driven by the rise in prevalence of infectious diseases, as it is considered to be the best way to prevent such diseases. In addition, emerging vaccines (Zika vaccines,  dengue vaccines, cancer vaccines, and others), production of technologically advanced vaccines, advancements in vaccine delivery devices, and increase in immunization programs supplement the market growth.

According to the market research study in 2016, the global vaccines market was worth US$ 28.0 Bn and is projected to reach a value of US$ 48.0 Bn by the end of 2025. The market is predicted to register a promising 6.0% CAGR between 2017 and 2025.